Modeling gene-by-environment interaction in comorbid depression with alcohol use disorders via an integrated bioinformatics approach by McEachin, Richard C et al.
BioMed CentralBioData Mining
ssOpen AcceResearch
Modeling gene-by-environment interaction in comorbid depression 
with alcohol use disorders via an integrated bioinformatics 
approach
Richard C McEachin*1,2, Benjamin J Keller2,3, Erika FH Saunders1 and 
Melvin G McInnis1,2
Address: 1Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA, 2National Center for Integrative Biomedical Informatics, 
University of Michigan, Ann Arbor, Michigan, USA and 3Department of Computer Science, Eastern Michigan University, Ypsilanti, Michigan, USA
Email: Richard C McEachin* - mceachin@umich.edu; Benjamin J Keller - bkeller@emich.edu; Erika FH Saunders - esaunder@umich.edu; 
Melvin G McInnis - mmcinnis@umich.edu
* Corresponding author    
Abstract
Background: Comorbidity of Major Depressive Disorder (depression) and Alcohol Use
Disorders (AUD) is well documented. Depression, AUD, and the comorbidity of depression with
AUD show evidence of genetic and environmental influences on susceptibility. We used an
integrated bioinformatics approach, mining available data in multiple databases, to develop and
refine a model of gene-by-environment interaction consistent with this comorbidity.
Methods: We established the validity of a genetic model via queries against NCBI databases,
identifying and validating TNF (Tumor Necrosis Factor) and MTHFR (Methylenetetrahydrofolate
Reductase) as candidate genes. We used the PDG-ACE algorithm (Prioritizing Disease Genes by
Analysis of Common Elements) to show that TNF and MTHFR share significant commonality and
that this commonality is consistent with a response to environmental exposure to ethanol. Finally,
we used MetaCore from GeneGo, Inc. to model a gene-by-environment interaction consistent with
the data.
Results: TNF Alpha Converting Enzyme (TACE) activity is suppressed by ethanol exposure,
resulting in reduced TNF signaling. TNF binds to TNF receptors, initiating signal transduction
pathways that activate MTHFR expression. MTHFR is an essential enzyme in folate metabolism and
reduced folate levels are associated with both AUD and depression. Integrating these pieces of
information our model shows how excessive alcohol use would be expected to lead to reduced
TNF signaling, reduced MTHFR expression, and increased susceptibility to depression.
Conclusion: The proposed model provides a novel hypothesis on the genetic etiology of
comorbid depression with AUD, consistent with established clinical and biochemical data. This
analysis also provides an example of how an integrated bioinformatics approach can maximize the
use of available biomedical data to improve our understanding of complex disease.
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Comorbidity of Major Depressive Disorder (depression)
with Alcohol Use Disorders (AUD) is well documented
[1]. Further, significant statistical association between
depression and alcohol dependence has long been estab-
lished [2]. For depressed individuals, the odds ratio for
alcohol dependence may be as high 4 to 7, relative to con-
trols, with a similar increase in prevalence of depression
among alcohol dependent individuals [3,4]. This associa-
tion between depression and AUD suggests that there may
be one or more common underlying elements influencing
susceptibility to both disorders.
Depression, AUD, and the comorbidity of depression
with AUD are complex traits, demonstrating both genetic
and environmental influences on susceptibility. Depres-
sion is familial, with estimates of heritability as high as
54% [5]. AUD is also familial, with heritability estimates
in the range of 50 to 60% [6]. Comorbidity of depression
with AUD also shows evidence of both genetic and shared
environmental influences [7-10]. Given evidence of asso-
ciation between depression and AUD, as well as evidence
that both the individual traits and the comorbidity are
influenced by both genetic and environmental factors, we
used an integrated bioinformatics approach, maximizing
the use of available data in multiple databases, to investi-
gate the hypothesis that interacting genetic and environ-
mental influences are common underlying elements of
susceptibility to comorbid depression with AUD. We
report the development and testing of a model of this
comorbidity, as well as implications for future research
into comorbid depression with AUD.
Methods
Queries against NCBI Databases
In this analysis, we used available data in NCBI databases,
plus three software suites (DAVID, PDG-ACE, and
GeneGo). To identify potential candidate genes, we que-
ried the Entrez Gene database [11] for "depression AND
ethanol AND human [orgn]". Since Entrez Gene surveys
the whole human genome, this approach is complemen-
tary to Whole Genome Association (WGA) analysis [12-
14]. WGA surveys many genetic variants (e.g. ~1 million
Single Nucleotide Polymorphisms (SNPs)) across the
genome, while this text-based query surveys all genes in
Entrez Gene. WGA provides indirect information on
potential associations of genes with disease by associating
nearby SNP variants with disease, while Entrez Gene que-
ries associate genes with disease based on curated text
describing the genes. Each approach has advantages and
disadvantages, highlighted in Table 1, though we believe
that the query-based approach offers significant advan-
tages in the initial phase of candidate gene analysis. First,
in recent years Entrez Gene has become a rich source of
information on many genes, while WGA typically focuses
on a very limited information source (e.g. SNP associa-
tion). Second, data provided by NCBI are free to the users.
While some of the genotypic and phenotypic data
required for WGA are becoming available in free public
repositories, these data are generally expensive to acquire.
Third, data derived from curated sources such as Entrez
Gene are backed by multiple rounds of experimentation
and peer review, so the believability of a positive result, as
measured by Positive Predictive Value [PPV = True Posi-
tives/(True positives + False Positives)], is very high. Given
these strengths, a query based approach should be consid-
ered for the initial phase of candidate gene analysis, which
Table 1: Comparison of Whole Genome Association (WGA) to text based, Entrez Gene, search for candidate genes.
Identifying Candidate Genes
WGA Text Based Search
Data Source Genotyping and Phenotyping Entrez Gene
Current Availability of Data Limited Available
Expense High Free (Taxpayer Subsidized)
Sensitivity Low; limited number of markers tested Low; much remains unknown about most genes
Positive Predictive Value Low; many false positives High; curated information is backed by experimental 
data and peer review
Population Specific Yes Generally no, although population specific information 
may be included in some records
Specific Variants Identified Yes, although SNPs that tag haplotypes may not 
be disease causing variants
Generally no, although specific variants may be 
annotated. Separate genotyping is usually required for 
validated candidates
Multi-Gene Effects on Phenotype Limited Yes
Complex Phenotypes Limited Yes
Text based searches, using data at NCBI as the first source for candidate gene data, provide advantages in data availability, price, and positive 
predictive value.Page 2 of 13
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testing.
The Entrez Gene database provides reliable information
about most genes, but the Entrez Gene record is a sum-
mary, so the information it provides is necessarily limited.
Therefore, we queried a second NCBI database, PubMed
[15], for more complete information on a variety of
hypotheses developed in this analysis. Table 2 shows the
short form of each PubMed query in column 1 and the
citation count is in column 2. For each PubMed query, the
actual query was qualified by Medical Subject Headings
(MeSH) annotation [16] and the detailed queries are
included in Additional file 1. Publications are annotated
by MeSH terminology to provide a consistent way to
retrieve information in publications that may use differ-
ent terminology for the same concepts. In addition, que-
rying PubMed by MeSH annotation yields a high
likelihood that publications returned by the query refer to
the queried terms in the appropriate context (high PPV).
For example, in looking for association between depres-
sion and AUD, we queried PubMed for "("Depressive Dis-
order" [Mesh] OR "Depression" [Mesh] OR "Depressive
Disorder, Major" [Mesh]) AND ("Ethanol" [Mesh] OR
"Alcohol-Induced Disorders, Nervous System" [Mesh])".
The resulting 263 citations returned are consistent with
the statistically significant association between depression
and AUD found by Hasin and Glick [2]. Using the Univer-
sity of Michigan's electronic journals library, we made an
exhaustive review the 263 citations returned by this query
to quantify the PPV of this MeSH qualified PubMed query.
In this review, we looked for clear evidence that the
authors were studying AUD and depression, in English
language publications, either full text or abstracts. We
were able to unequivocally assess the accuracy of MeSH
annotation for AUD and depression in 179 citations. Of
these 179 publications, 171 clearly refer to both AUD and
depression, though not necessarily the comorbidity of
AUD with depression. Of the eight remaining publica-
tions, five are correctly annotated for ethanol, but ethanol
is used as an important reagent in the experimental proce-
dures. The final three publications are incorrectly anno-
tated for ethanol, though they refer to pharmacologically
related chemicals (flupenthixol, haloperidol, and pir-
buterol). We consider these eight publications to be false
positives with respect to our original query, yielding a
95.5% (171/179) PPV for our query.
There are, however, limitations to the use of MeSH anno-
tation in querying publications. First, while MeSH con-
tains thousands of Medical Subject Headings, it is not an
exhaustive annotation of all potential biomedical con-
texts. Second, there may be missing annotation or ambi-
guity in the annotation for some publications. For
example, as mentioned in the PPV analysis, not all of the
171 papers that we counted as True Positives were specif-
ically about comorbid AUD with depression. The earlier
papers tended to refer to AUD and depression as co-occur-
ring phenotypes, while the later papers focused on evalu-
ating the comorbidity. There also may be ambiguity in the
user's choice of MeSH terms queried, and some publica-
tions may report negative associations, though the bias
against publication of negative results minimizes the
number of these papers. And finally, a lack of citations is
not evidence of a lack of association. While co-occurrence
of queried terms is not proof of association, co-occurrence
does provide a quantitative measure of peer reviewed
research on the association of these specific terms and
complements other forms of data that can be mined. In
future analyses, Natural Language Processing will help to
improve these queries by mining the full text of publica-
tions for a wide variety of concepts, and provide addi-
tional evidence of association among terms. Given
believable candidate genes, derived from queries of avail-
able data at Entrez Gene and PubMed, we continued the
analysis using DAVID, PDG-ACE, and MetaCore
(GeneGo, Inc.) to understand how these candidate genes
may be related to the etiology of AUD, depression, and
comorbid AUD with depression.
DAVID, PDG-ACE, and GeneGo
DAVID software, the PDG-ACE algorithm, and the
GeneGo suite perform related tasks. The essential assump-
tion in the use of all three tools is that, in complex dis-
eases, multiple genetic influences converge on a single
Table 2: PubMed queries and citation counts
Short form, PubMed Queries PubMed Citation Count
depression AND ethanol 263
depression AND MTHFR 12
ethanol AND MTHFR 5
depression AND ethanol AND MTHFR 0
depression AND TNF 92
ethanol AND TNF 321
depression AND ethanol AND TNF 1
depression AND NFkB 2
ethanol AND NFkB 185
depression AND ethanol AND NFkB 0
depression AND TNFR 19
ethanol AND TNFR 44
depression AND ethanol AND TNFR 0
depression and APOE 91
ethanol and APOE 42
depression AND ethanol AND APOE 0
PubMed queries were used to search for evidence consistent with 
various hypotheses on 9 December, 2007. Queries were qualified by 
Medical Subject Headings (MeSH) annotation to minimize spurious 
associations. The actual queries, including MeSH qualifications, are 
provided as Additional file 1. Column 1 has a short form of the query 
and column 2 shows the number of citations that meet the query 
criteria.Page 3 of 13
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identify how multiple genes may influence the phenotype
of interest and assess the statistical significance of the
results seen.
DAVID [17] uses a database of available gene annotation
to overlay candidate genes onto predefined gene sets. For
example, genes may be organized into predefined sets
based on annotation for their participation in a Gene
Ontology function, process, or component [18]. A set of
candidate genes is then derived from a genotype/pheno-
type analysis (e.g. WGA, microarray expression, or text-
based database query) and the candidate genes are over-
laid on the predefined gene sets. If a large proportion of
the candidate genes are found to be annotated for a given
gene set (e.g. an over-represented Gene Ontology proc-
ess), the candidate genes may have an important impact
on the process represented by that gene set. Since the can-
didate genes were initially derived from a genotype/phe-
notype relationship, the over-represented process may be
important in the phenotype [19].
However, since much gene annotation remains incom-
plete, PDG-ACE [20] [see Additional file 2] serves as an
adjunct to software that depends on gene annotation. As
noted, the Entrez Gene database offers a reliable summary
of information on a wide range of genetic and environ-
mental influences for each gene (e.g. gene function, dis-
ease influences, localization, environmental effects).
However, much of the information available in Entrez
Gene is free text, rather than formal annotation, limiting
the use of tools like DAVID. We created the PDG-ACE
algorithm to overcome this limitation by mining Entrez
Gene text to identify biomedical keywords that are com-
mon and significantly over-represented in the descrip-
tions of genes at a selected locus pair, relative to all locus
pairs in the genome.
The PDG-ACE algorithm uses a controlled vocabulary of
biomedical keywords to limit the search to  concepts
likely to be useful in understanding disease etiology and
show statistically significant over-representation. For a
given locus pair, PDG-ACE mines the Entrez Gene text to
find keywords from the controlled vocabulary that are
common across the locus pair. For keywords that are com-
mon across the locus pair, significance of over-representa-
tion is established by permutation testing. Keywords that
are common and significantly over-represented across the
locus pair highlight rare combinations of genes that share
the biomedical concepts associated with the keywords.
Testing of the PDG-ACE algorithm, using both positive
controls (documented gene-gene interactions in complex
disease) and negative controls (randomly selected gene
pairs), demonstrates that PDG-ACE provides insight into
the etiology of true genetic interactions, while excluding
loci where the data is insufficient to identify interactions
[20]. As with DAVID, the loci are initially defined by the
disease phenotype, so the over-represented keywords may
offer insight into the nature of a genetic interaction in dis-
ease etiology. In applying the PDG-ACE algorithm, we
define genetic interaction to mean a "statistically signifi-
cant multi-gene or multi-gene-by-environment influence
on the phenotype", consistent with Hartman et al. [21].
This definition is deliberately broad, allowing PDG-ACE
to identify unannotated influences on the phenotype,
ranging from well-defined influences (e.g. epistasis, pro-
tein-protein binding, canalization, genetic robustness,
buffering) to completely novel influences, as long as the
influence is multi-gene (or multi-gene-by-environment)
and statistically significant. The complete list of keywords
used in this analysis is included in Additional file 3. Soft-
ware implementing the PDG-ACE algorithm is available
on request from Dr. Ben Keller, bkeller@emich.edu.
The GeneGo suite [22] uses the MetaCore database of doc-
umented gene-gene (protein-protein) interactions [23], as
well as a set of graphical and statistical tools, to allow
researchers to build gene networks based on relationships
among genes. The MetaCore interactive database has been
manually curated from publications describing interac-
tions among proteins and small molecules of biological
relevance in humans. We used GeneGo to place our can-
didate genes into a cellular context, evaluate the signifi-
cance of gene networks that our candidates participate in,
and build a model that integrates all of the information
derived in our analysis. Specifics of the parameter settings
used in the GeneGo analysis are included in Table 3.
Notably, we accepted only direct interactions, curated by
human reviewers.
Results
Based on prior evidence consistent with genetic and envi-
ronmental influences on susceptibility to comorbid
depression with AUD, we started the analysis with the
hypothesis that genetic influences participate in depres-
sion and AUD. Figure 1 shows the analysis flow, including
the initial hypothesis, three rounds of hypothesis testing
and generation, and model building based on the results
of our testing.
Genetic Influences on Comorbidity
We first searched for evidence of genetic influences on
depression and AUD by querying NCBI's Entrez Gene
database for "depression AND ethanol AND human
[orgn]". This query returned exactly three genes: Tumor
Necrosis Factor (TNF superfamily, member 2, GeneID
7124), Methylenetetrahydrofolate Reductase (MTHFR,
5,10-methylenetetrahydrofolate reductase (NADPH),
GeneID 4524) [24-29], and APOE (apolipoprotein E,
GeneID 348). However, the Gene Ontology annotationPage 4 of 13
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tronic annotation, rather than manual curation. In an
effort to use only the most reliable information to estab-
lish our initial candidate genes, we excluded APOE from
the formal analysis. However, we have included a brief
analysis of APOE in the results.
We searched PubMed for supporting information on
potential roles of the proteins coded by TNF and MTHFR
in depression, AUD, and comorbid depression with AUD.
In searching PubMed, we found evidence that both TNF
and MTHFR have been associated with depression and
with ethanol in the literature, but not with the comorbid-
ity of depression with AUD (Table 2). Notably, the result
in Table 2 showing that TNF is associated with both
depression and ethanol in a single publication is one of
the false positive results identified in the PPV analysis. We
didn't find evidence of MTHFR being associated with both
depression and AUD in any single paper.
In total, the published literature is consistent with the
hypothesis that TNF and MTHFR may both influence, or
be influenced by, depression and AUD. We consider TNF
and MTHFR to be valid candidate genes for both depres-
sion and AUD. Given these candidate genes, we next
sought evidence that they participate in the comorbidity
via genetic interaction.
Interaction between TNF and MTHFR via DAVID and 
PDG-ACE
Given evidence of genetic influences on depression and
AUD, we refined the hypothesis to include interaction
between TNF and MTHFR. We first used DAVID software
to explore functional annotation consistent with interac-
tion between TNF and MTHFR. DAVID looks for over-rep-
resentation of candidate genes in signaling or metabolic
pathways, Gene Ontology processes, etc., based on avail-
able gene annotation. TNF and MTHFR were not found to
be significantly over-represented in any gene set tested by
DAVID.
Since most genes are only partially annotated, we next
explored potential interactions between TNF and MTHFR
via the PDG-ACE algorithm [20]. A total of 149 keywords
were found to be common across the TNF/MTHFR gene
pair, out of 2,531 keywords in this controlled vocabulary.
We checked these 149 common keywords for over-repre-
sentation using 10 million iterations in permutation test-
ing. After a Bonferroni correction for 2,531 hypothesis
tests, 27 keywords were found to be significantly over-rep-
resented (p-value < 0.05) in the TNF/MTHFR gene pair,
relative to randomly selected gene pairs in the human
genome. Six of these 27 keywords were found to be used
in different contexts in the TNF and MTHFR Entrez Gene
records and were eliminated; leaving 21 keywords that are
common and significantly over-represented across the
TNF/MTHFR gene pair (Table 4). Given this evidence of
interaction between TNF and MTHFR in AUD and depres-
sion, and consistent with expected environmental influ-
ences on complex diseases, we further refined the
hypothesis to include gene-by-environment interaction
influencing the comorbidity.
Environmental Influence of Ethanol Exposure
Each significantly over-represented keyword identified by
PDG-ACE represents one hypothesis on the etiology of a
genetic interaction between TNF and MTHFR in depres-
sion and AUD. We tested each of these hypotheses by que-
rying PubMed for "depression AND ethanol AND
keyword" (Table 4). As in the previous round of testing, we
Table 3: Parameter settings used in GeneGo analysis
Options Setting
Use canonical pathways Yes
Network type Merged
Build options Analyze network (transcription factors)
Advanced options
Discard objects user list No
Use indirect interactions Discard
Use interactions weights No
Add complementary objects Yes
Filter interactions by confidence level Curated only
Use binding interactions (special cases) Discard
Group networks No
Discard objects experiments No
Use unspecified reactions Discard
GeneGo analysis was performed with MetaCore™ version 4.5, build 11165, on 26 November 2007. TNF and MTHFR were the input gene set.Page 5 of 13
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citation counts to provide indications of relevant associa-
tion in the literature. Notably, since ethanol is a keyword
in the PDG-ACE controlled vocabulary that we used, it
acts as a positive control in this analysis and is the top key-
word when ranked by relevance. In addition to ethanol,
the top keywords ranked by relevance to depression and
AUD are "consumption", "background", and "intake". In
the Entrez Gene records for TNF and MTHFR, intake and
consumption both refer to intake of alcohol, while back-
ground refers specifically to genetic background. Results
of the PDG-ACE analysis are consistent with the hypothe-
sis that genetic background, via TNF and MTHFR, as well
as environmental influences, via alcohol intake or con-
sumption, are interacting elements of susceptibility in
comorbid depression with AUD. Given evidence of
genetic interaction between TNF and MTHFR, as well as
gene-by-environment interaction in comorbid depression
with AUD, we next sought to understand TNF and MTHFR
in a cellular context.
Model Building via GeneGo
We used the GeneGo suite [22,23] to place TNF and
MTHFR in a cellular context. Results of the PDG-ACE
analysis suggested that ethanol consumption exerts an
environmental influence on this genetic system. Also, TNF
is a secreted protein that responds to the environment by
binding TNF receptors to influence intracellular signal
transduction pathways that regulate gene expression.
Given these inputs, we focused our GeneGo analysis on
cell signaling via signal transduction and the regulation of
gene expression within the cell (input parameters in Table
3).
The most significant network found by GeneGo (Figure 2)
shows a feedback loop among TNF (a.k.a. TNF-alpha),
TNF-R1 (a.k.a. TNFRSF1A, GeneID 7132), and NF-kB
(a.k.a. NFKB1, GeneID 4790). Note that these proteins do
not act in isolation, but the GeneGo graphic shows the
essential elements of the network based on annotation in
GeneGo's MetaCore database. In the network identified
by GeneGo, conditions in the extracellular environment
Analysis FlowFigure 1
Analysis Flow. Analysis started with prior evidence of potential genetic and environmental influences on comorbidity, fol-
lowed by testing for genetic influences, genetic interactions, and environmental influences. The resulting model of gene-by-envi-
ronment interaction is consistent with clinical and biochemical data.
Hypothesis: One or more genetic 
Influence(s) on Comorbidity
Candidate genes identified and 
validated via NCBI database queries
Hypothesis: Genetic Interaction 
Between TNF and MTHFR
Evidence consistent with hypothesis 
via PDG-ACE algorithm
Hypothesis: Environmental Influence(s) 
of Ethanol on TNF and MTHFR
Evidence consistent with hypothesis via 
keyword association with comorbidity 
Gene-by-Environment Interaction
Modeled and tested via GeneGo 
ANALYSIS FLOW
Prior Evidence: Comorbidity and 
Familiality of Depression with AUDPage 6 of 13
(page number not for citation purposes)
BioData Mining 2008, 1:2 http://www.biodatamining.org/content/1/1/2are sensed inside the cell via binding of TNF to TNF-R1,
activating TNF-R1 [30,31]. Activated TNF-R1 activates NF-
kB [32,33], which subsequently activates the expression of
both TNF [34] and MTHFR [35,36]. Given the potential
for TNF-R1 and NF-kB to impact this network, we queried
PubMed for potential influences of these genes on depres-
sion and AUD (Table 2). We found citations consistent
with roles for both of these genes in depression and AUD.
Genetic variation or extracellular signals that affect any
part of the feedback cycle (Figure 2) would tend to be
amplified over a number of cycles, potentially leading to
a growing imbalance in the system over time. In this net-
work, NF-kB activates the expression of MTHFR, which
metabolizes folate, so imbalances in the system would be
expected to lead to imbalances in folate metabolism. This
result is consistent with evidence of decreased folate levels
in alcoholism [37]. In addition, reduced folate levels are
associated with depression [38], where research on etiol-
ogy suggests that reduced folate levels may alter neuro-
transmitter metabolism [39-41].
Summarizing our results to this point, we found evidence
that both TNF and MTHFR are associated with both
depression and alcohol in the literature, TNF and MTHFR
interact to influence the comorbidity and alcohol exerts
an environmental influence on this genetic network, and
folate levels are altered in both depression and alcohol
dependence. Investigating the environmental influence of
ethanol on TNF, we found that ethanol intake suppresses
the function of TNF Alpha Converting Enzyme (TACE,
a.k.a. ADAM17, GeneID 6868) [28], leading to reduced
TNF signaling. Integrating these lines of evidence, we pro-
pose a model of comorbid depression with AUD (Figure
3). In this model, environmental ethanol exposure sup-
presses TNF signaling by inhibiting TACE [28]. Reduced
TNF signaling reduces TNF-R1 activation [30,31], which
then reduces NF-kB activation [32]. NF-kB activates the
expression of both TNF [33,34] and MTHFR [35,36], so
reduced NF-kB activation contributes to further reduction
in TNF signaling as well as reduced MTHFR expression.
Reduced expression of MTHFR would be expected to alter
folate metabolism and increase susceptibility to depres-
sion [38].
Table 4: Significant biomedical keywords identified by PDG-ACE 
across the TNF/MTHFR gene pair, and relevance to depression 
with AUD
Keyword # PubMed citations for query:
Ethanol 263
Consumption 29
Background 12
Intake 10
Child 9
Mortality 6
Transplant 2
Mineral 1
Hemodialysis 0
Abdominal 0
Carotid 0
Wall 0
Preoperative 0
Lumbar 0
kidney transplantation 0
Spine 0
Homozygote 0
Mediterranean 0
hormone replacement therapy 0
p53 gene 0
Sickle 0
Each keyword derived from the PDG-ACE analysis (column 1) was 
queried against the PubMed database via the query: ("Depressive 
Disorder" [Mesh] OR "Depression" [Mesh] OR "Depressive 
Disorder, Major" [Mesh]) AND ("Ethanol" [Mesh] OR "Alcohol-
Induced Disorders, Nervous System" [Mesh]) AND Keyword. Citation 
counts are used as an indication of the keyword's relevance in 
comorbid depression with AUD.
Top scoring GeneGo network including TNF and MTHFRFigure 2
Top scoring GeneGo network including TNF and 
MTHFR. This four-gene network is the best fit found by 
GeneGo (p-value 3.45e-08) for TNF and MTHFR. TNF 
(TNF-alpha) activates TNFR (TNF-R1), which then activates 
NF-kB. NF-kB regulates the expression of both MTHFR and 
TNF, creating a feedback loop among TNF, TNFR, and NF-
kB.Page 7 of 13
(page number not for citation purposes)
BioData Mining 2008, 1:2 http://www.biodatamining.org/content/1/1/2Signal transduction, leading to transcriptional regulation
of both TNF and MTHFR, is an essential assumption of
this model. In addition to building networks, GeneGo
analyzes networks for over-representation of genes that
participate in Gene Ontology (GO) processes (similar to
the DAVID analysis described), then ranks the GO proc-
esses by p-value. Table 5 shows that "positive regulation
of transcription from RNA polymerase II promoter" is the
most significantly over-represented GO process in this
network. This result is consistent with the hypothesis that
environmental influences, via ethanol exposure, are trans-
duced through this genetic network to alter TNF and
Proposed Model of Comorbid Depression with AUDFigure 3
Proposed Model of Comorbid Depression with AUD. This model, incorporating evidence gathered in hypothesis test-
ing, and consistent with an environmental effect of ethanol on the genetic network, shows how ethanol consumption would be 
expected to result in decreased folate metabolism and increased susceptibility to depression for genetically susceptible individ-
uals.
6. Increased
Susceptibility
to Depression
1.  Ethanol
Exposure
Suppresses
TNF
Processing
by TACE
2. Reduced
Activation 
of TNFR1
and 3. NFkB
5. Reduced
Expression 
of MTHFR
4. Reduced
Expression 
of TNF
Table 5: Ranking of Gene Ontology processes for GeneGo network in Figure 2
Gene Ontology Process p-value
positive regulation of transcription from RNA polymerase II promoter 3.8E-06
negative regulation of interleukin-12 biosynthetic process 5.3E-06
inflammatory response 9.5E-06
positive regulation of I-kappaB kinase/NF-kappaB cascade 1.5E-05
positive regulation of transcription, DNA-dependent 1.5E-05
regulation of I-kappaB kinase/NF-kappaB cascade 1.8E-05
positive regulation of transcription 2.9E-05
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process 3.3E-05
regulation of interleukin-12 biosynthetic process 3.8E-05
interleukin-12 biosynthetic process 3.8E-05
response to wounding 3.9E-05
interleukin-12 production 4.8E-05
Regulation of transcription is the most significantly over-represented Gene Ontology process for this network, consistent with the hypothesis that 
environmental influences, via ethanol exposure, are transduced through this genetic network to alter TNF and MTHFR expression, folate 
metabolism, and susceptibility to depression.Page 8 of 13
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to depression.
Apolipoprotein E (APOE) was excluded from the formal
analysis because the annotation in Entrez Gene was
inferred, rather than curated. In pursuing the hypothesis
that APOE is involved in comorbid depression with AUD,
we re-started the analysis including APOE. We queried
PubMed for citations consistent with this hypothesis
(Table 2) and found evidence of APOE's role in both
depression and AUD, but no evidence for a role in the
comorbidity. PDG-ACE analysis did not produce any sig-
nificant results after correction for multiple hypothesis
tests. We attempted to insert APOE into the GeneGo net-
work (Figure 2) and found no annotated interactions
between APOE and the other genes in the network. Apol-
ipoprotein E may well have an influence on comorbid
depression with AUD but, if so, the mechanism is either
independent of the network modeled or, more likely, the
data is not yet available to reliably connect APOE to this
network.
Discussion
Comorbid depression with AUD shows evidence of both
genetic and environmental influences on susceptibility. In
three phases of hypothesis generation and testing (NCBI
database queries, PDG-ACE and GeneGo analyses) we
established and tested a model of gene-by-environment
interaction that shows evidence of influencing the comor-
bidity and is consistent with established knowledge about
AUD and depression [37]. We first hypothesized that
common genetic influences affect AUD and depression.
We tested this hypothesis by searching for candidate genes
and found published evidence, via Entrez Gene and
PubMed, supporting the roles of TNF and MTHFR in
depression and AUD. Given evidence of a multi-gene
influence on the comorbidity, we hypothesized that TNF
and MTHR participate in a genetic interaction influencing
the comorbidity. Mining the Entrez Gene records for TNF
and MTHFR via the PDG-ACE algorithm, we found twenty
one keywords that are common and significantly over-
represented across the gene pair, consistent with interac-
tion between these genes in comorbid AUD with depres-
sion. In addition, among the significant keywords, those
that are most often associated with depression and AUD
in the literature are suggestive of an environmental effect
on this genetic interaction via ethanol intake or consump-
tion. Given evidence that TNF and MTHFR participate in
a genetic interaction that may be influenced by environ-
mental exposure to ethanol, as well as evidence that TNF
influences signal transduction pathways in response to
the environment, we hypothesized signal transduction as
the most appropriate model of the gene-by-environment
interaction. Modeling this hypothesis via GeneGo, we
found that both TNF and MTHFR are influenced by a
genetic feedback cycle that incorporates environmental
ethanol exposure into folate metabolism. Altered folate
levels, as well as AUD, are consistently linked to depres-
sion [42-44].
Mason and Choi [37] review other mechanisms
(decreased dietary intake of folate, decreased intestinal
absorption, increased urinary secretion, and cleavage of
the folate molecule) that have been purported to reduce
the bio-availability of folate with excessive ethanol intake.
In addition, they review the adverse effects that ethanol
can have on one-carbon metabolism, a process that
includes the synthesis of folate. Mason and Choi show
five enzymes involved in one-carbon metabolism includ-
ing MTHFR, Cystathionine beta-synthase (CBS, GeneID
875), Betaine Homocysteine Methyltransferase (BHMT,
GeneID 635), Serine Hydroxymethyltransferase 1 (SHMT,
GeneID 6470), and Methionine Synthase (MTR, GeneID
4548). Figure 4 is a GeneGo graphic showing how TNF
signaling may impact every one of these enzymes by regu-
lating their expression. This network, still fairly simple,
includes all of the elements of the proposed model (Fig-
ure 2) and provides a suggestion of how AUD impacts
one-carbon metabolism in a complex genotype-pheno-
type relationship. Arguably, because all of the enzymes
seen in this network affect folate metabolism, they all are
candidates for influencing comorbid depression with
AUD.
Based on the relationship between folate metabolism and
one-carbon metabolism, we searched for evidence that the
one-carbon metabolic process influences depression,
AUD, and the comorbidity. Table 6 shows evidence that
several of these genes may have influences on depression
or AUD. The larger hypotheses, depression AND folate,
ethanol AND folate, show 133 and 237 citations, respec-
tively, though we did not find evidence for depression
AND ethanol AND folate. In Figure 4, two additional
genes, p53 (TP53, GeneID 7157) and HNF4a (HNF4-
alpha, GeneID 3172), are shown to participate in the net-
work. Searching for evidence of these genes in depression,
AUD, and the comorbidity, we found evidence for associ-
ation between p53 and ethanol (Table 6). Interestingly,
"p53 gene" is one of the 21 keywords that we found to be
common and significantly overrepresented across the
TNF/MTHFR gene pair in the PDG-ACE analysis (Table 4).
Notably, while the evidence assembled in this analysis is
consistent with our hypothesized model of gene-by-envi-
ronment interaction of comorbid depression with AUD,
much data remains missing. For example, we emphasize
the environmental influence of alcohol consumption,
though we have little information on how alcohol dosage
or the duration of alcohol exposure might affect genetic
influences in our model. Equally, while we have identifiedPage 9 of 13
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we have limited information on heritable variation that
would be expected to increase or decrease susceptibility.
To date, the C677T variant of MTHFR is associated with
both susceptibility to depression [27,45,46] and ethanol
response [26], and levels of TNF mRNA have been associ-
ated with depression [25]. Cytogenetic band 6p21, the
chromosomal location of TNF, has recently been associ-
ated with chromosomal aberrations in alcoholism [47].
However, the genetic influences of this network are likely
to be much more complex than what we know so far.
Missing data on these influences await follow-on analyses
(e.g., targeted genotyping in an affected population versus
controls, animal modelling) that can be informed by the
model developed here. Also, given the model proposed,
future data from WGA or microarray studies can be tested
on a reduced number of hypotheses, thus increasing the
power of these tools.
Implications
Implications of this model are consistent with dietary
guidance recommending monitoring and appropriate
supplementation of folate for patients in treatment for
depression [48-50], AUD, or comorbid depression with
AUD [37,38,42-44]. In addition, identification of the var-
iants associated with risk could be useful in prognosis and
treatment of either or both conditions [51]. Pharmacoge-
nomic approaches are being successfully implemented in
psychiatry, to the great benefit of patients with specific
genetic variants [52-54], and the identification of disease
predisposing variants will likely improve the prognosis for
depression with AUD.
Conclusion
The model developed in this analysis represents one
mechanism whereby, for genetically susceptible individu-
als, alcohol intake could lead to altered folate metabolism
and increased susceptibility to depression. The effect of
GeneGo graphic illustrating how TNF signaling impacts one-carbon metabolismFigure 4
GeneGo graphic illustrating how TNF signaling impacts one-carbon metabolism. Folate metabolism is one element 
of one-carbon metabolism and TNF signaling influences all of the enzymes involved. As a result, variations in any of the genes 
involved in one-carbon metabolism could influence folate metabolism and susceptibility to depression.Page 10 of 13
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[37] but this analysis puts the environmental effect of
alcohol consumption into a genetic context and provides
a model for further hypothesis testing.
Candidate gene approaches offer a necessarily limited
view of gene-disease association because so much data is
missing on virtually all genes. In addition, data mining
approaches, if not carefully controlled, can lead to false
positive associations. However, by starting with the most
reliable data available to select candidate genes, using
multiple lines of evidence to test the validity of candi-
dates, then putting the candidates into context, we believe
we have developed one valid model of gene-by-environ-
ment interaction influencing comorbid depression with
AUD. The proposed gene-by-environment interaction
model provides a biologically plausible and testable
hypothesis on the genetic etiology of comorbid depres-
sion with AUD.
With appropriate caveats, this approach to complex dis-
ease analysis could be applied to understanding many dis-
eases. Both publication bias towards positive results and
bias towards genes that are commonly studied will tend to
steer text based evidence in the direction of a relatively
limited set of genes. This bias will be countered by the
large volumes of data currently being generated without
prior hypotheses. In particular, WGA and microarray data
are being deposited in publicly available datasets. These
data will complement text based approaches by allowing
for unbiased tests of the reduced number of hypotheses
posed. Indeed, as the volume of data available in data-
bases increases, this type of analysis will become more val-
uable.
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